Editorial
Published on 16 Mar 2023
Editorial: Advances in antimicrobial therapy and combating resistance
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1170289
- 977 views
- 1 citation
Type at least 3 characters
316 articles
Articles
Original Research
Published on 15 Mar 2023
Antibiotic consumption and antimicrobial resistance in the SARS-CoV-2 pandemic: A single-center experience
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1067973
- 4,215 views
- 10 citations
Original Research
Published on 14 Mar 2023
Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1067295
- 3,075 views
- 4 citations
Original Research
Published on 13 Mar 2023
Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmacokinetic/pharmacodynamic analysis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1135007
- 2,333 views
- 3 citations
Review
Published on 09 Mar 2023
An update on SARS-CoV-2 immunization and future directions
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1125305
- 4,132 views
- 8 citations
Clinical Trial
Published on 09 Mar 2023
Evaluating the efficacy of inhaled amikacin as an adjunct to intravenous combination therapy (ceftazidime and amikacin) in pediatric cystic fibrosis pulmonary exacerbation
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1130374
- 3,851 views
- 2 citations
Review
Published on 08 Mar 2023
Ebanga™: The most recent FDA-approved drug for treating Ebola
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1083429
- 11,363 views
- 11 citations
Original Research
Published on 02 Mar 2023
Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1118584
- 2,385 views
Review
Published on 02 Mar 2023
Barriers and facilitators to maintaining a high level of polypharmacy adherence in people living with HIV: A scoping review
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1013688
- 2,702 views
- 1 citation
Original Research
Published on 02 Mar 2023
The impact of pharmacist early active consultation (PEAC) on multidrug resistance organism treatment outcomes: A prospective historically controlled study
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1128219
- 1,313 views
- 1 citation
Original Research
Published on 01 Mar 2023
Innovative, rapid, high-throughput method for drug repurposing in a pandemic—A case study of SARS-CoV-2 and COVID-19
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1130828
- 3,041 views
- 4 citations
Original Research
Published on 24 Feb 2023
Molluskicidal nanoemulsion of Neomitranthes obscura (DC.) N. Silveira for schistosomiasis control
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1078936
- 1,596 views
Review
Published on 24 Feb 2023
Antibacterial sensitizers from natural plants: A powerful weapon against methicillin-resistant Staphylococcus aureus
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1118793
- 4,224 views
- 7 citations
Clinical Trial
Published on 17 Feb 2023
Evaluation of noscapine-licorice combination effects on cough relieving in COVID-19 outpatients: A randomized controlled trial
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1102940
- 3,534 views
- 2 citations
Data Report
Published on 10 Feb 2023
The challenges of open data for future epidemic preparedness: The experience of the 2022 Ebolavirus outbreak in Uganda
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1101894
- 3,283 views
- 8 citations
Original Research
Published on 07 Feb 2023
Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1090717
- 5,232 views
- 18 citations